STOCK TITAN

Catheter Precision’s VIVO System Featured in Electrophysiology Publication

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary
Catheter Precision, Inc. (NYSE American:VTAK) announced that their VIVO System was featured in a case study in EP Lab Digest, a publication dedicated to electrophysiology. The case study, presented by physicians at NYU, combines two different mapping platforms for ventricular arrhythmias, demonstrating the benefits of pre-procedural planning.
Positive
  • None.
Negative
  • None.

FORT MILL, SC / ACCESSWIRE / January 17, 2024 / Catheter Precision, Inc. (the "Company") (NYSE American:VTAK), a leader in non-invasive 3D mapping for ventricular arrhythmias, announced that their VIVO System was highlighted as part of a case study in the current issue of EP Lab Digest. EP Lab Digest is an educational, monthly publication dedicated to electrophysiology with both print and online content.

"Physicians often present case studies to publications for new and innovative products." Said David Jenkins, CEO of Catheter Precision. "Having a case study selected means that the publication committee believes the work presented by the physicians at NYU is valuable for other electrophysiologists. This case study is unique in that it falls under a physician-initiated study and combines two different mapping platforms further streamlining the benefits of pre-procedural planning."

About VIVO

Catheter Precision's VIVO™ (View Into Ventricular Onset), is a non-invasive 3D imaging system that enables physicians to identify the origin of ventricular arrhythmias pre-procedure, thereby streamlining workflow and reducing procedure time. VIVO has received marketing clearance from the U.S. FDA and is commercially available in the EU.

About Catheter Precision

Catheter Precision is an innovative U.S.-based medical device company bringing new solutions to market to improve the treatment of cardiac arrhythmias. It is focused on developing groundbreaking technology for electrophysiology procedures by collaborating with physicians and continuously advancing its products. Reincorporated as Ra Medical Systems, Inc. in Delaware in 2018, the Company changed its name to Catheter Precision, Inc. on August 17, 2023.

CONTACTS:

At the Company

David Jenkins
973-691-2000
IR@catheterprecision.com

# # #

SOURCE: Catheter Precision, Inc



View the original press release on accesswire.com

FAQ

What is the name of the company mentioned in the case study?

Catheter Precision, Inc.

What is the ticker symbol for Catheter Precision, Inc.?

The ticker symbol is VTAK.

What was highlighted as part of the case study in EP Lab Digest?

The VIVO System by Catheter Precision, Inc.

What is EP Lab Digest?

EP Lab Digest is a publication dedicated to electrophysiology with both print and online content.

Who presented the case study in EP Lab Digest?

Physicians at NYU presented the case study.

What is unique about the case study?

It falls under a physician-initiated study and combines two different mapping platforms for ventricular arrhythmias.

What are the benefits demonstrated in the case study?

The benefits of pre-procedural planning for ventricular arrhythmias.

Who is the CEO of Catheter Precision, Inc.?

David Jenkins is the CEO of Catheter Precision, Inc.

Catheter Precision, Inc.

NYSE:VTAK

VTAK Rankings

VTAK Latest News

VTAK Stock Data

1.46M
2.80M
16.78%
2.53%
2.15%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
FORT MILL